Health Expert Craig Stoltz shares health management news and commentary at HealthCentral.com. HealthCentral.com is one of the top health destinations on the Web, with more than 35 condition-specific, wellness and general health Web properties. http://www.healthcentral.com/profiles/c/827/index http://www.healthcentral.com/profiles/c/827/rss self application/xml en-us 15 120 19 http://www.healthcentral.com/images/hc_logo_sm.gif http://www.healthcentral.com/profiles/c/827/index http://www.healthcentral.com/cholesterol/c/827/23800/vytorin-things Tue, 01 Apr 2008 12:29:00 -0400 Craig Stoltz Another week, another set of studies calling into question the benefits and risks of a widely used drug. This time it's Vytorin, a cholesterol-lowering drug that combines a statin (in this case Zocor) with a drug that lowers bad cholesterol a different way (Zetia, aka ezetimibe).  As usual, the story is getting political (Congressional hearings to determine whether negative data was withheld) and financial (shares in drugmakers Merck... http://www.healthcentral.com/cholesterol/c/827/23800/vytorin-things http://www.healthcentral.com/cholesterol/c/827/12356/hdl-harder Thu, 16 Aug 2007 00:00:01 -0400 Craig Stoltz Most efforts to battle arterial clogging focus on lowering LDL, so called "bad" cholesterol. But higher levels of HDL, the good cholesterol, are also linked to better heart health. A new report shows that efforts to raise HDL with drugs have proven to be trickier, and riskier, than lowering LDL. Let's dig in. Bottom line first  There's only sketchy evidence that using drugs to boost HDL cholesterol is effective in... http://www.healthcentral.com/cholesterol/c/827/12356/hdl-harder